Cargando…

Effect on bone anabolic markers of daily cheese intake with and without vitamin K(2): a randomised clinical trial

BACKGROUND: Daily intake of 57 g Jarlsberg cheese has been shown to increase the total serum osteocalcin (tOC). Is this a general cheese effect or specific for Jarlsberg containing vitamin K(2) and 1,4-dihydroxy-2naphtoic acid (DHNA)? METHODS: 66 healthy female volunteers (HV) were recruited. By ske...

Descripción completa

Detalles Bibliográficos
Autores principales: Lundberg, Helge Einar, Glasø, Morten, Chhura, Rahul, Shukla, Arjun Andre, Austlid, Torunn, Sarwar, Zohaib, Hovland, Kathrine, Iqbal, Sapna, Fagertun, Hans Erik, Holo, Helge, Larsen, Stig Einride
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813627/
https://www.ncbi.nlm.nih.gov/pubmed/36619332
http://dx.doi.org/10.1136/bmjnph-2022-000424
_version_ 1784863960784175104
author Lundberg, Helge Einar
Glasø, Morten
Chhura, Rahul
Shukla, Arjun Andre
Austlid, Torunn
Sarwar, Zohaib
Hovland, Kathrine
Iqbal, Sapna
Fagertun, Hans Erik
Holo, Helge
Larsen, Stig Einride
author_facet Lundberg, Helge Einar
Glasø, Morten
Chhura, Rahul
Shukla, Arjun Andre
Austlid, Torunn
Sarwar, Zohaib
Hovland, Kathrine
Iqbal, Sapna
Fagertun, Hans Erik
Holo, Helge
Larsen, Stig Einride
author_sort Lundberg, Helge Einar
collection PubMed
description BACKGROUND: Daily intake of 57 g Jarlsberg cheese has been shown to increase the total serum osteocalcin (tOC). Is this a general cheese effect or specific for Jarlsberg containing vitamin K(2) and 1,4-dihydroxy-2naphtoic acid (DHNA)? METHODS: 66 healthy female volunteers (HV) were recruited. By skewed randomisation (3:2), 41 HV were allocated to daily intake of 57 g Jarlsberg (J-group) and 25–50 g Camembert (C-group) in 6 weeks. After 6 weeks the C-group was switched to Jarlsberg. The study duration was 12 weeks with clinical investigations every 6 weeks. The main variables were procollagen type 1 N-terminal propeptide (PINP), tOC, carboxylated osteocalcin (cOC) and the osteocalcin ratio (R(O)) defined as the ratio between cOC and undercarboxylated osteocalcin (ucOC). Serum cross-linked C-telopeptide type I collagen (CTX), vitamin K(2), lipids and clinical chemistry were used as secondary variables. RESULTS: PINP, tOC, cOC, R(O) and vitamin K(2) increased significantly (p<0.01) after 6 weeks in the J-group. PINP remained unchanged in the C-group. The other variables decreased slightly in the C-group but increased significantly (p≤0.05) after switching to Jarlsberg. No CTX-changes detected in neither of the groups. Serum lipids increased slightly in both groups. Switching to Jarlsberg, total cholesterol and low-density lipoprotein-cholesterol were significantly reduced (p≤0.05). Glycated haemoglobin (HbA1c), Ca(++) and Mg(++) were significantly reduced in the J-group, but unchanged in the C-group. Switching to Jarlsberg, HbA1c and Ca(++) decreased significantly. CONCLUSION: The effect of daily Jarlsberg intake on increased s-osteocalcin level is not a general cheese effect. Jarlsberg contain vitamin K(2) and DHNA which increases PINP, tOC, cOC and R(O) and decreases Ca(++), Mg(++) and HbA1c. These effects reflect increased bone anabolism and a possible reduced risk of adverse metabolic outcomes. TRIAL REGISTRATION NUMBER: NCT04189796.
format Online
Article
Text
id pubmed-9813627
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-98136272023-01-06 Effect on bone anabolic markers of daily cheese intake with and without vitamin K(2): a randomised clinical trial Lundberg, Helge Einar Glasø, Morten Chhura, Rahul Shukla, Arjun Andre Austlid, Torunn Sarwar, Zohaib Hovland, Kathrine Iqbal, Sapna Fagertun, Hans Erik Holo, Helge Larsen, Stig Einride BMJ Nutr Prev Health Original Research BACKGROUND: Daily intake of 57 g Jarlsberg cheese has been shown to increase the total serum osteocalcin (tOC). Is this a general cheese effect or specific for Jarlsberg containing vitamin K(2) and 1,4-dihydroxy-2naphtoic acid (DHNA)? METHODS: 66 healthy female volunteers (HV) were recruited. By skewed randomisation (3:2), 41 HV were allocated to daily intake of 57 g Jarlsberg (J-group) and 25–50 g Camembert (C-group) in 6 weeks. After 6 weeks the C-group was switched to Jarlsberg. The study duration was 12 weeks with clinical investigations every 6 weeks. The main variables were procollagen type 1 N-terminal propeptide (PINP), tOC, carboxylated osteocalcin (cOC) and the osteocalcin ratio (R(O)) defined as the ratio between cOC and undercarboxylated osteocalcin (ucOC). Serum cross-linked C-telopeptide type I collagen (CTX), vitamin K(2), lipids and clinical chemistry were used as secondary variables. RESULTS: PINP, tOC, cOC, R(O) and vitamin K(2) increased significantly (p<0.01) after 6 weeks in the J-group. PINP remained unchanged in the C-group. The other variables decreased slightly in the C-group but increased significantly (p≤0.05) after switching to Jarlsberg. No CTX-changes detected in neither of the groups. Serum lipids increased slightly in both groups. Switching to Jarlsberg, total cholesterol and low-density lipoprotein-cholesterol were significantly reduced (p≤0.05). Glycated haemoglobin (HbA1c), Ca(++) and Mg(++) were significantly reduced in the J-group, but unchanged in the C-group. Switching to Jarlsberg, HbA1c and Ca(++) decreased significantly. CONCLUSION: The effect of daily Jarlsberg intake on increased s-osteocalcin level is not a general cheese effect. Jarlsberg contain vitamin K(2) and DHNA which increases PINP, tOC, cOC and R(O) and decreases Ca(++), Mg(++) and HbA1c. These effects reflect increased bone anabolism and a possible reduced risk of adverse metabolic outcomes. TRIAL REGISTRATION NUMBER: NCT04189796. BMJ Publishing Group 2022-08-02 /pmc/articles/PMC9813627/ /pubmed/36619332 http://dx.doi.org/10.1136/bmjnph-2022-000424 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Lundberg, Helge Einar
Glasø, Morten
Chhura, Rahul
Shukla, Arjun Andre
Austlid, Torunn
Sarwar, Zohaib
Hovland, Kathrine
Iqbal, Sapna
Fagertun, Hans Erik
Holo, Helge
Larsen, Stig Einride
Effect on bone anabolic markers of daily cheese intake with and without vitamin K(2): a randomised clinical trial
title Effect on bone anabolic markers of daily cheese intake with and without vitamin K(2): a randomised clinical trial
title_full Effect on bone anabolic markers of daily cheese intake with and without vitamin K(2): a randomised clinical trial
title_fullStr Effect on bone anabolic markers of daily cheese intake with and without vitamin K(2): a randomised clinical trial
title_full_unstemmed Effect on bone anabolic markers of daily cheese intake with and without vitamin K(2): a randomised clinical trial
title_short Effect on bone anabolic markers of daily cheese intake with and without vitamin K(2): a randomised clinical trial
title_sort effect on bone anabolic markers of daily cheese intake with and without vitamin k(2): a randomised clinical trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813627/
https://www.ncbi.nlm.nih.gov/pubmed/36619332
http://dx.doi.org/10.1136/bmjnph-2022-000424
work_keys_str_mv AT lundberghelgeeinar effectonboneanabolicmarkersofdailycheeseintakewithandwithoutvitamink2arandomisedclinicaltrial
AT glasømorten effectonboneanabolicmarkersofdailycheeseintakewithandwithoutvitamink2arandomisedclinicaltrial
AT chhurarahul effectonboneanabolicmarkersofdailycheeseintakewithandwithoutvitamink2arandomisedclinicaltrial
AT shuklaarjunandre effectonboneanabolicmarkersofdailycheeseintakewithandwithoutvitamink2arandomisedclinicaltrial
AT austlidtorunn effectonboneanabolicmarkersofdailycheeseintakewithandwithoutvitamink2arandomisedclinicaltrial
AT sarwarzohaib effectonboneanabolicmarkersofdailycheeseintakewithandwithoutvitamink2arandomisedclinicaltrial
AT hovlandkathrine effectonboneanabolicmarkersofdailycheeseintakewithandwithoutvitamink2arandomisedclinicaltrial
AT iqbalsapna effectonboneanabolicmarkersofdailycheeseintakewithandwithoutvitamink2arandomisedclinicaltrial
AT fagertunhanserik effectonboneanabolicmarkersofdailycheeseintakewithandwithoutvitamink2arandomisedclinicaltrial
AT holohelge effectonboneanabolicmarkersofdailycheeseintakewithandwithoutvitamink2arandomisedclinicaltrial
AT larsenstigeinride effectonboneanabolicmarkersofdailycheeseintakewithandwithoutvitamink2arandomisedclinicaltrial